Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals

Last updated: April 22, 2024
Sponsor: Western University of Health Sciences
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Aging

Macular Degeneration

Geographic Atrophy

Treatment

Nature Made (gummy)

Nature Made (soft gel)

OmegaBoost

Clinical Study ID

NCT05763940
GHS.002
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaIndex (OmegaQuant) research.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • not currently taking Omega-3 supplements or fish oils
  • able to swallow softgel or chew gummies nutritional supplement daily for a 12 weekperiod
  • able to make four (4) follow-up visits

Exclusion

Exclusion Criteria:

  • allergy to fish or seafood
  • h/o Atrial fibrillation, or at risk of Afib
  • h/o congestive heart failure, heart disease, or prior myocardial infarction and/orcerebrovascular accident
  • noncompliance with study requirements

Study Design

Total Participants: 130
Treatment Group(s): 3
Primary Treatment: Nature Made (gummy)
Phase:
Study Start date:
May 25, 2022
Estimated Completion Date:
June 25, 2024

Connect with a study center

  • Western University of Health Sciences

    Pomona, California 91766
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.